Abacus Life (ABL)
NASDAQ:ABL
US Market
Advertisement

Abacus Life (ABL) AI Stock Analysis

Compare
147 Followers

Top Page

ABL

Abacus Life

(NASDAQ:ABL)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 4o)
Rating:62Neutral
Price Target:
$7.00
▲(4.32% Upside)
Abacus Life's overall stock score is driven by strong earnings call performance and strategic initiatives, which are offset by challenges in profitability and valuation. The technical analysis suggests potential short-term volatility, while financial performance indicates areas for improvement in cash flow and profitability.
Positive Factors
Revenue Growth
Sustained revenue growth indicates strong market demand and effective business strategies, enhancing Abacus Life's competitive position.
Strategic Initiatives
The introduction of dividends and share buybacks reflects confidence in financial stability and commitment to enhancing shareholder value.
Operational Efficiency
Improved EBITDA growth suggests strong operational efficiency, which can lead to better profitability and long-term financial health.
Negative Factors
Profitability Challenges
Negative profitability indicates challenges in converting revenue into profit, which could impact long-term financial sustainability.
Cash Flow Issues
Negative cash flow growth can limit the company's ability to invest in growth opportunities and meet financial obligations, affecting future stability.
Increased Operating Expenses
Rising operating expenses could pressure future margins, potentially impacting profitability and financial performance over time.

Abacus Life (ABL) vs. SPDR S&P 500 ETF (SPY)

Abacus Life Business Overview & Revenue Model

Company DescriptionAbacus Global Management, Inc. operates as an alternative asset manager and market maker in the United States. It operates in five segments: Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. The Active Management segment is involved in the buying, selling, and trading of policies; and the maintenance of policies until receipt of death benefits. Its Originations segment originates life insurance policy settlements between investors or buyers, and the sellers, who are often the original policy owners. The Asset Management segment provides asset management services to investors investing in alternative investment and equity portfolio funds based on fund investment agreements. Its Portfolio Servicing segment offers policy services to customers on a contract basis. The Technology Services segment provides real-time mortality verification, missing participant verification, and other services specific to the life insurance market services to customers on a contract basis. It sells its products through financial advisors or agents, direct-to-consumer, and traditional life settlements intermediaries. The company was formerly known as Abacus Life, Inc. and changed its name to Abacus Global Management, Inc. in February 2025. Abacus Global Management, Inc. was founded in 2004 and is headquartered in Orlando, Florida.
How the Company Makes MoneyAbacus Life generates revenue primarily through the acquisition of life insurance policies at a discount to their face value. The company earns money by collecting the death benefits upon the policyholder's passing, which typically exceeds the initial purchase price. Key revenue streams include the premiums paid on acquired policies, the appreciation in policy value, and potential investment income from the capital used to purchase these policies. Additionally, ABL may engage in partnerships with financial institutions and brokers that facilitate policy acquisitions, further enhancing its revenue potential through commission structures and referral fees.

Abacus Life Earnings Call Summary

Earnings Call Date:Nov 06, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 19, 2026
Earnings Call Sentiment Positive
The earnings call for Abacus Global Management highlighted strong financial performance and strategic advancements, such as substantial revenue growth, profitability, and the introduction of dividends and share buybacks. However, challenges include below-expected capital deployment and increased operating expenses. Despite these lowlights, the overall sentiment leans positive due to the significant achievements and strategic initiatives underscored during the call.
Q3-2025 Updates
Positive Updates
Record-Breaking Revenue Growth
Abacus Global Management reported a total revenue increase of 124% year-over-year to $63 million, marking their 10th consecutive quarter of beating consensus projections.
Adjusted Net Income and EBITDA Growth
Adjusted net income rose 60% to $23.6 million, and adjusted EBITDA increased 127% to $37.9 million, reflecting strong profitability and operational efficiency.
Initiation of Dividend and Share Repurchase Program
Abacus announced the initiation of an annual dividend of $0.20 per share and a $10 million share repurchase program, demonstrating confidence in their strategy and financial stability.
Securitization Milestone
Abacus completed a $50 million above investment-grade securitization product note backed by life insurance assets, opening a new institutional distribution channel and validating institutional demand for longevity-linked assets.
Asset Management Segment Performance
The asset management segment generated $8.6 million in revenue during Q3, with $102 million of new inflows, showcasing successful strategic M&A activity.
Negative Updates
Capital Deployed Below Expectations
Capital deployed was $102 million in Q3, which was below the second quarter but still resulted in solid life settlements revenues. This reflects strategic deployment but indicates potential capacity constraints.
High Turnover and Holding Period Discrepancies
The annualized turnover ratio was 2x, with policies sold having an average holding period of 363 days compared to 253 days for policies still owned, highlighting potential inefficiencies in portfolio management.
Increase in Operating Expenses
Total operating expenses increased to $32.9 million from $19.4 million in the prior year, due to acquired companies' expenses, increased G&A, depreciation, amortization, and marketing investments, which could pressure future margins.
Company Guidance
During the Abacus Global Management Third Quarter 2025 Earnings Call, CEO Jay Jackson highlighted that the company achieved a record quarter, marking their tenth consecutive quarter of surpassing consensus projections. Total revenue for Q3 2025 increased 124% year-over-year, reaching $63 million, while adjusted net income rose 60% to $23.6 million. Adjusted EBITDA also saw a significant increase of 127%, amounting to $37.9 million. As a result of these strong financial performances, Abacus raised its 2025 guidance to $80 million to $84 million, representing a year-over-year growth of 72% to 81%. The company also introduced an annual dividend of $0.20 per share and announced a $10 million share repurchase program to enhance shareholder value. Key strategic moves, such as the recent acquisition of AccuQuote, are expected to further drive growth and strengthen Abacus' competitive position.

Abacus Life Financial Statement Overview

Summary
Abacus Life demonstrates strong revenue growth and operational efficiency, but faces challenges in profitability and cash flow management. The balance sheet is stable with moderate leverage, yet the negative return on equity indicates inefficiencies. Overall, the company needs to focus on improving profitability and cash flow generation to enhance financial health.
Income Statement
65
Positive
Abacus Life shows a strong revenue growth rate of 21.54% TTM, indicating a positive trajectory. However, the net profit margin is negative at -0.72% TTM, reflecting profitability challenges. The EBIT margin of 20.03% TTM is healthy, suggesting operational efficiency, but the EBITDA margin of 28.95% TTM indicates room for improvement in managing non-operating expenses.
Balance Sheet
70
Positive
The company's debt-to-equity ratio of 0.86 TTM is moderate, indicating a balanced approach to leveraging. However, the return on equity is negative at -0.30% TTM, highlighting inefficiencies in generating returns for shareholders. The equity ratio of 47.84% TTM suggests a stable capital structure with a solid equity base.
Cash Flow
50
Neutral
Abacus Life's free cash flow growth rate is negative at -14.99% TTM, indicating cash flow challenges. The operating cash flow to net income ratio of 0.19 TTM suggests limited cash generation from operations. Additionally, the free cash flow to net income ratio of -4.84 TTM highlights significant cash flow management issues.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue196.55M111.92M66.40M44.71M22.59M1.22M
Gross Profit172.01M100.55M59.91M38.83M8.39M710.01K
EBITDA56.55M6.76M23.78M34.81M1.03M-457.29K
Net Income11.04M-23.96M9.52M31.68M997.41K1.44M
Balance Sheet
Total Assets918.94M874.16M331.83M59.09M1.84M3.74M
Cash, Cash Equivalents and Short-Term Investments86.42M131.94M27.84M30.05M2.60M1.85M
Total Debt124.71M385.91M141.74M28.33M1.05M148.97K
Total Liabilities479.34M450.87M167.76M30.95M1.07M160.70K
Stockholders Equity439.59M424.15M163.93M27.25M915.05K2.08M
Cash Flow
Free Cash Flow-111.14M-209.62M-64.71M10.61M1.12M904.09K
Operating Cash Flow46.55M-208.81M-64.52M10.69M1.34M650.13K
Investing Cash Flow-17.77M-4.96M2.24M-3.70M-241.53K-1.25M
Financing Cash Flow208.31M320.12M57.82M22.96M-354.58K697.81K

Abacus Life Technical Analysis

Technical Analysis Sentiment
Positive
Last Price6.71
Price Trends
50DMA
5.96
Positive
100DMA
5.83
Positive
200DMA
6.72
Negative
Market Momentum
MACD
0.06
Negative
RSI
66.65
Neutral
STOCH
83.06
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ABL, the sentiment is Positive. The current price of 6.71 is above the 20-day moving average (MA) of 5.62, above the 50-day MA of 5.96, and below the 200-day MA of 6.72, indicating a neutral trend. The MACD of 0.06 indicates Negative momentum. The RSI at 66.65 is Neutral, neither overbought nor oversold. The STOCH value of 83.06 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ABL.

Abacus Life Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$3.77B4.4916.27%27.71%
71
Outperform
$3.93B14.4211.12%1.61%-1.61%15.79%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
66
Neutral
$293.94M26.385.02%-0.55%-51.14%
62
Neutral
$487.69M-79.123.17%91.78%
60
Neutral
$3.50B19.282.86%1.41%150.35%
49
Neutral
$60.17M29.742.45%0.68%6.98%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ABL
Abacus Life
6.71
-2.04
-23.31%
AAME
Atlantic American
3.00
1.31
77.51%
CIA
Citizens
5.69
1.30
29.61%
CNO
CNO Financial
41.64
3.04
7.88%
GNW
Genworth Financial
8.49
1.16
15.83%
BHF
Brighthouse Financial
65.82
14.48
28.20%

Abacus Life Corporate Events

Abacus Global Management’s Earnings Call Highlights Robust Growth
Nov 8, 2025

The recent earnings call for Abacus Global Management painted a largely positive picture, highlighting the company’s robust financial performance and strategic advancements. Despite some challenges, such as below-expected capital deployment and rising operating expenses, the overall sentiment was optimistic. The company showcased significant achievements, including substantial revenue growth, profitability, and the introduction of dividends and share buybacks, underscoring a strong strategic direction.

Business Operations and StrategyStock BuybackDividends
Abacus Life Announces $10M Stock Repurchase Program
Positive
Nov 7, 2025

On November 6, 2025, Abacus Global Management announced a $10 million stock repurchase program and an annual cash dividend of $0.20 per share, reflecting confidence in its long-term business model and capital strength. The initiatives are part of a broader capital allocation strategy aimed at enhancing shareholder value through consistent returns and strategic growth investments, funded by cash on hand and free cash flow.

The most recent analyst rating on (ABL) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Abacus Life stock, see the ABL Stock Forecast page.

Abacus Global Management Reports Strong Q3 2025 Results
Nov 7, 2025

Abacus Global Management, Inc. is a prominent player in the alternative asset management sector, specializing in longevity-based assets and offering data-driven wealth solutions and technology innovations. The company has reported its third-quarter results for 2025, marking its tenth consecutive quarter of earnings growth, with significant revenue and net income increases. Abacus Global Management achieved a record revenue growth of $63.0 million, a 124% increase year-over-year, and a GAAP net income of $7.1 million. The company’s adjusted net income rose by 60% to $23.6 million, while adjusted EBITDA increased by 127% to $37.9 million. The company also completed strategic acquisitions, including AccuQuote, and issued a $50 million securitized asset-backed note. Looking forward, Abacus Global Management has raised its full-year 2025 outlook, expecting adjusted net income growth between 72% and 81%, reflecting confidence in its strategic initiatives and market position.

Business Operations and StrategyFinancial DisclosuresM&A TransactionsPrivate Placements and Financing
Abacus Life Reports Strong Q3 2025 Earnings Growth
Positive
Nov 6, 2025

On November 6, 2025, Abacus Global Management reported its third-quarter 2025 results, marking the tenth consecutive quarter of earnings growth. The company achieved a record revenue growth of 124% year-over-year, reaching $63.0 million, and increased its adjusted net income by 60% to $23.6 million. Abacus also completed the strategic acquisition of AccuQuote and announced a $50 million securitized asset-backed rated note, enhancing its financial services platform and creating a scalable funding mechanism. These achievements have reinforced the company’s momentum and visibility in the market, with an increased full-year 2025 outlook for adjusted net income growth between 72% and 81%.

The most recent analyst rating on (ABL) stock is a Buy with a $13.50 price target. To see the full list of analyst forecasts on Abacus Life stock, see the ABL Stock Forecast page.

Business Operations and StrategyDelistings and Listing ChangesFinancial Disclosures
Abacus Life Raises 2025 Outlook Amid Revenue Surge
Positive
Sep 25, 2025

In a letter to shareholders dated September 25, 2025, Abacus Life reported nearly doubling its year-over-year revenue and adjusted net income, driven by strong demand for its investment products. The company raised its full-year 2025 outlook for adjusted net income, expecting growth of 59% to 72%, and announced its inclusion in the Russell 2000 and Russell 3000 indices. Despite a recent short attack, Abacus has maintained confidence among stakeholders and continues to focus on its growth strategy. The company introduced new key performance indicators to enhance transparency and demonstrate its value creation capabilities. Abacus’s business model, which integrates four synergistic verticals, is positioned for substantial market opportunities, aiming for sustainable, profitable growth.

The most recent analyst rating on (ABL) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on Abacus Life stock, see the ABL Stock Forecast page.

Abacus Life Shines in Earnings Call with Robust Growth
Aug 13, 2025

Abacus Life, Inc. recently held its earnings call, revealing a strong performance characterized by substantial revenue growth, increased net income, and successful asset management inflows. Despite some concerns over high operating expenses and related party transactions, the overall sentiment was positive, indicating robust business momentum.

Abacus Global Management Reports Strong Q2 2025 Results
Aug 8, 2025

Abacus Global Management, Inc. is a prominent player in the alternative asset management sector, offering innovative financial solutions and leveraging data analytics to optimize outcomes for clients worldwide. In its second quarter of 2025, Abacus reported a significant increase in total revenue, nearly doubling to $56.2 million compared to the previous year. The company also saw substantial capital inflows into its longevity funds, amounting to $123.1 million.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 08, 2025